These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1531780)

  • 1. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects.
    Bauch M; Ester A; Kimura B; Victorica BE; Kedar A; Phillips MI
    Cancer; 1992 Mar; 69(6):1492-7. PubMed ID: 1531780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
    Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
    Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer.
    Tikanoja T; Riikonen P; Perkkiö M; Helenius T
    Med Pediatr Oncol; 1998 Aug; 31(2):73-8. PubMed ID: 9680930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors.
    Kula S; Tunaoglu FS; Olgunturk R; Gokcora N
    Can J Cardiol; 2003 Mar; 19(4):405-8. PubMed ID: 12704487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
    Tulevski II; Groenink M; van Der Wall EE; van Veldhuisen DJ; Boomsma F; Stoker J; Hirsch A; Lemkes JS; Mulder BJ
    Heart; 2001 Jul; 86(1):27-30. PubMed ID: 11410557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
    Okumura H; Iuchi K; Yoshida T; Nakamura S; Takeshima M; Takamatsu H; Ikeno A; Usuda K; Ishikawa T; Ohtake S; Matsuda T
    Acta Haematol; 2000; 104(4):158-63. PubMed ID: 11279304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy.
    Wondergem J; Strootman EG; Frölich M; Leer JW; Noordijk EM
    Radiother Oncol; 2001 Mar; 58(3):295-301. PubMed ID: 11230891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
    Lerman A; Gibbons RJ; Rodeheffer RJ; Bailey KR; McKinley LJ; Heublein DM; Burnett JC
    Lancet; 1993 May; 341(8853):1105-9. PubMed ID: 8097801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.